59 related articles for article (PubMed ID: 2896176)
1. Interference in follicular maturation following acute intranasal LH-RH agonist administration during mid and late follicular phase.
Lemay A; Faure N
Int J Fertil; 1988; 33(1):60-7. PubMed ID: 2896176
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of ovulation during discontinuous intranasal luteinizing hormone-releasing hormone agonist dosing in combination with gestagen-induced bleeding.
Lemay A; Faure N; Labrie F; Fazekas AT
Fertil Steril; 1985 Jun; 43(6):868-77. PubMed ID: 3158551
[TBL] [Abstract][Full Text] [Related]
3. GnRH agonist as luteal phase support in assisted reproduction technique cycles: results of a pilot study.
Pirard C; Donnez J; Loumaye E
Hum Reprod; 2006 Jul; 21(7):1894-900. PubMed ID: 16556673
[TBL] [Abstract][Full Text] [Related]
4. Fourteen-day versus twenty-one-day regimens of intermittent intranasal luteinizing hormone-releasing hormone agonist combined with an oral progestogen as antiovulatory contraceptive approach.
Lemay A; Faure N
J Clin Endocrinol Metab; 1986 Dec; 63(6):1379-85. PubMed ID: 2946711
[TBL] [Abstract][Full Text] [Related]
5. Steroid receptor expression in late follicular phase endometrium in GnRH antagonist IVF cycles is already altered, indicating initiation of early luteal phase transformation in the absence of secretory changes.
Papanikolaou EG; Bourgain C; Kolibianakis E; Tournaye H; Devroey P
Hum Reprod; 2005 Jun; 20(6):1541-7. PubMed ID: 15705618
[TBL] [Abstract][Full Text] [Related]
6. Luteolytic activity of LHRH and [D-Ser(TBU)6, des-Gly-NH2(10)]LHRH ethylamide: a new and physiological approach to contraception in women.
Lemay A; Labrie F; Raynaud JP
Int J Fertil; 1980; 25(3):203-12. PubMed ID: 6108931
[TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of low dose hCG for luteal support after triggering ovulation with a GnRH agonist in cases of polyfollicular development.
Krause BT; Ohlinger R
Eur J Obstet Gynecol Reprod Biol; 2006 May; 126(1):87-92. PubMed ID: 16377065
[TBL] [Abstract][Full Text] [Related]
8. Suppression of follicular maturation by infusion of a luteinizing hormone-releasing hormone agonist starting during the late luteal phase in the stumptailed macaque monkey.
Fraser HM; Sandow J
J Clin Endocrinol Metab; 1985 Mar; 60(3):579-84. PubMed ID: 3919049
[TBL] [Abstract][Full Text] [Related]
9. Ovarian sonographic findings during intermittent intranasal luteinizing hormone-releasing hormone agonist sequentially combined with an oral progestogen as antiovulatory contraceptive approach.
Lemay A; Faure N; Bastide A
Fertil Steril; 1987 Jan; 47(1):60-6. PubMed ID: 2947818
[TBL] [Abstract][Full Text] [Related]
10. Chronic treatment with the gonadotropin-releasing hormone agonist D-Ser(TBU)6-EA10-LRH for contraception in women and men.
Nillius SJ; Bergquist C; Wide L
Int J Fertil; 1980; 25(3):239-46. PubMed ID: 6108935
[TBL] [Abstract][Full Text] [Related]
11. Effects of a preovulatory single low dose of mifepristone on ovarian function.
van der Stege JG; Pahl-van Beest EH; Beerthuizen RJ; van Lunsen RH; Scholten PC; Bogchelman DH
Eur J Contracept Reprod Health Care; 2006 Jun; 11(2):104-8. PubMed ID: 16854683
[TBL] [Abstract][Full Text] [Related]
12. Gonadotroph and corpus luteum responses to two successive intranasal doses of a luteinizing hormone-releasing hormone agonist at different days after the midcycle luteinizing hormone surge.
Lemay A; Faure N; Labrie F; Fazekas AT
Fertil Steril; 1983 May; 39(5):661-7. PubMed ID: 6404660
[TBL] [Abstract][Full Text] [Related]
13. Sensitivity of pituitary and corpus luteum responses to single intranasal administration of (D-ser[TBU]6-des-gly-NH2(10)) luteinizing hormone-releasing hormone ethylamide (Buserelin) in normal women.
Lemay A; Faure N; Labrie F
Fertil Steril; 1982 Feb; 37(2):193-200. PubMed ID: 6800846
[TBL] [Abstract][Full Text] [Related]
14. Gonadotropins and estradiol responses to single intranasal or subcutaneous administration of a luteinizing hormone-releasing hormone agonist in the early follicular phase.
Lemay A; Metha AE; Tolis G; Faure N; Labrie F; Fazekas AT
Fertil Steril; 1983 May; 39(5):668-73. PubMed ID: 6404661
[TBL] [Abstract][Full Text] [Related]
15. Rapid inhibitory effects of an LHRH agonist implant on the oestrogen-induced LH surge and the induction of a defective luteal phase after an agonist-induced ovulation in the macaque.
Fraser HM; Lunn SF
Hum Reprod; 1989 Jul; 4(5):506-12. PubMed ID: 2507574
[TBL] [Abstract][Full Text] [Related]
16. Early follicular phase luteinizing hormone-releasing hormone agonist administration - effects on follicular maturation and corpus luteum function in women.
Skarin G; Nillius SJ; Wide L
Contraception; 1982 Jan; 25(1):31-9. PubMed ID: 6800690
[TBL] [Abstract][Full Text] [Related]
17. [Contraception by cyclic treatment with buserelin and progesterone].
Wieacker P; Breckwoldt M; Greif M; Geisthövel F
Geburtshilfe Frauenheilkd; 1991 Feb; 51(2):135-9. PubMed ID: 1904039
[TBL] [Abstract][Full Text] [Related]
18. Long-acting agonists of LH-RH in the treatment of large ovarian endometriomas.
Cortes-Prieto J; Lledo A; Avila C; Cortes-Garcia L; D'Acunto A; Luisi M; Comaru-Schally AM; Schally AV
Int J Fertil; 1987; 32(4):290-7. PubMed ID: 2887526
[TBL] [Abstract][Full Text] [Related]
19. Immediate pre-ovulatory administration of 30 mg ulipristal acetate significantly delays follicular rupture.
Brache V; Cochon L; Jesam C; Maldonado R; Salvatierra AM; Levy DP; Gainer E; Croxatto HB
Hum Reprod; 2010 Sep; 25(9):2256-63. PubMed ID: 20634186
[TBL] [Abstract][Full Text] [Related]
20. Short-term administration of antivascular endothelial growth factor antibody in the late follicular phase delays follicular development in the rhesus monkey.
Zimmermann RC; Xiao E; Husami N; Sauer MV; Lobo R; Kitajewski J; Ferin M
J Clin Endocrinol Metab; 2001 Feb; 86(2):768-72. PubMed ID: 11158044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
